Stonepine Capital Management LLC Has $299,000 Stake in Establishment Labs Holdings Inc. $ESTA

Stonepine Capital Management LLC decreased its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 90.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,000 shares of the company’s stock after selling 67,500 shares during the quarter. Stonepine Capital Management LLC’s holdings in Establishment Labs were worth $299,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. CWM LLC increased its position in Establishment Labs by 45.9% in the 2nd quarter. CWM LLC now owns 2,182 shares of the company’s stock valued at $93,000 after acquiring an additional 686 shares in the last quarter. Patriot Financial Group Insurance Agency LLC lifted its position in shares of Establishment Labs by 5.2% during the second quarter. Patriot Financial Group Insurance Agency LLC now owns 6,025 shares of the company’s stock worth $257,000 after purchasing an additional 300 shares in the last quarter. ARS Investment Partners LLC bought a new stake in shares of Establishment Labs during the second quarter valued at approximately $278,000. ADAR1 Capital Management LLC acquired a new stake in shares of Establishment Labs in the first quarter valued at approximately $326,000. Finally, SG Americas Securities LLC raised its position in Establishment Labs by 94.2% in the 2nd quarter. SG Americas Securities LLC now owns 8,712 shares of the company’s stock worth $372,000 after purchasing an additional 4,226 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on ESTA shares. Canaccord Genuity Group increased their price objective on Establishment Labs from $60.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Citigroup reaffirmed a “neutral” rating on shares of Establishment Labs in a research note on Tuesday, October 7th. Mizuho boosted their price target on shares of Establishment Labs from $70.00 to $85.00 and gave the stock an “outperform” rating in a research note on Thursday, November 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Establishment Labs in a research note on Monday. Finally, Wall Street Zen raised shares of Establishment Labs from a “sell” rating to a “hold” rating in a report on Sunday, October 19th. Six equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Establishment Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $68.29.

Establishment Labs Stock Performance

Shares of NASDAQ:ESTA opened at $67.76 on Thursday. The firm’s 50 day simple moving average is $54.07 and its 200 day simple moving average is $44.78. Establishment Labs Holdings Inc. has a fifty-two week low of $26.56 and a fifty-two week high of $72.33. The company has a market capitalization of $1.97 billion, a price-to-earnings ratio of -23.86 and a beta of 1.01. The company has a debt-to-equity ratio of 15.06, a current ratio of 3.33 and a quick ratio of 2.10.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings data on Wednesday, November 5th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.54) by $0.16. Establishment Labs had a negative net margin of 43.45% and a negative return on equity of 235.45%. The firm had revenue of $53.78 million during the quarter, compared to analysts’ expectations of $52.28 million. During the same quarter in the previous year, the company earned ($0.59) earnings per share. The business’s revenue for the quarter was up 33.8% on a year-over-year basis. As a group, sell-side analysts forecast that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.